1. Home
  2. OVV vs RGEN Comparison

OVV vs RGEN Comparison

Compare OVV & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ovintiv Inc. (DE)

OVV

Ovintiv Inc. (DE)

HOLD

Current Price

$37.33

Market Cap

9.9B

Sector

Energy

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$162.51

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OVV
RGEN
Founded
2020
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OVV
RGEN
Price
$37.33
$162.51
Analyst Decision
Buy
Buy
Analyst Count
14
10
Target Price
$49.50
$174.90
AVG Volume (30 Days)
3.1M
701.7K
Earning Date
11-04-2025
10-28-2025
Dividend Yield
3.21%
N/A
EPS Growth
N/A
N/A
EPS
0.90
0.03
Revenue
$8,794,000,000.00
$707,890,000.00
Revenue This Year
N/A
$17.84
Revenue Next Year
$1.65
$12.57
P/E Ratio
$41.52
$5,259.20
Revenue Growth
N/A
11.74
52 Week Low
$29.80
$102.97
52 Week High
$46.35
$182.52

Technical Indicators

Market Signals
Indicator
OVV
RGEN
Relative Strength Index (RSI) 39.49 54.15
Support Level $37.05 $156.01
Resistance Level $38.86 $165.02
Average True Range (ATR) 1.15 4.65
MACD -0.54 -1.07
Stochastic Oscillator 4.64 43.33

Price Performance

Historical Comparison
OVV
RGEN

About OVV Ovintiv Inc. (DE)

Ovintiv Inc is a North American oil and natural gas exploration and production company that is focused on developing its multi-basin portfolio of high-quality assets located in the United States and Canada. Its operations also include the marketing of oil, NGLs and natural gas. The company has two operating segments: USA Operations, and Canadian Operations. The USA Operations include the exploration for, development of, and production and marketing of oil, NGLs, natural gas and other related activities within the United States. The Canadian Operations include the exploration for, development of, and production and marketing of oil, NGLs, natural gas and other related activities within Canada.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: